Expertise in
33
conditions

Dr. Neil S. Horowitz

Obstetrics and Gynecology | Oncology | Gynecologic Oncology
Dana-Farber Cancer Institute, Inc.
450 Brookline Ave, 
Boston, MA 
Accepting New Patients
Offers Telehealth
Expertise in
33
conditions
Dana-Farber Cancer Institute, Inc.
450 Brookline Ave, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neil Horowitz is an Obstetrics and Gynecologist and an Oncologist in Boston, Massachusetts. Dr. Horowitz is highly rated in 33 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Vulvar Cancer, Endometrial Cancer, Hysterectomy, and Salpingo-Oophorectomy. Dr. Horowitz is currently accepting new patients.

His clinical research consists of co-authoring 194 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Obstetrics and Gynecology
Oncology
Gynecologic Oncology
Licenses
Obstetrics & Gynecology in MA
Hospital Affiliations
Milford Regional Medical Center
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Tufts
  • HMO

Locations

DANA-FARBER CANCER INSTITUTE, INC.
450 Brookline Ave, Boston, MA 02215
Other Locations
BRIGHAM AND WOMENS PHYSICIANS ORGANIZATION INC
75 Francis St, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2025
Intervention Type: Other, Biological
Study Drug: Vigil
Study Phase: Phase 2
WISP (Women Choosing Surgical Prevention)
WISP (Women Choosing Surgical Prevention)
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Other, Drug, Biological
Study Drugs: Dactinomycin, Leucovorin Calcium, Methotrexate
Study Phase: Phase 3
A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva (NCT #01595061)
A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva (NCT #01595061)
Enrollment Status: Unknown
Publish Date: December 29, 2021
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Cisplatin, Gemcitabine Hydrochloride
Study Phase: Phase 2
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Enrollment Status: Terminated
Publish Date: May 04, 2020
Intervention Type: Procedure
Study Phase: Not Applicable
View 5 Less Clinical Trials

194 Total Publications

Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
Journal: JCO precision oncology
Published: April 10, 2025
Similar Doctors
Expertise in
30
conditions
Dr. Ross S. Berkowitz
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
30
conditions
Dr. Ross S. Berkowitz
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.1 mi)
617-632-3586
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ross Berkowitz is a Gynecologic Oncologist and an Oncologist in Boston, Massachusetts. Dr. Berkowitz is highly rated in 30 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Gestational Trophoblastic Disease, Hydatidiform Mole, Oophorectomy, and Salpingo-Oophorectomy. Dr. Berkowitz is currently accepting new patients.

Expertise in
31
conditions
Dr. Colleen M. Feltmate
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
31
conditions
Dr. Colleen M. Feltmate
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (0.1 mi)
617-732-5500
Languages Spoken:
English
Offers Telehealth

Colleen Feltmate is a Gynecologic Oncologist and an Oncologist in Boston, Massachusetts. Dr. Feltmate is highly rated in 31 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Vulvar Cancer, Ovarian Cancer, Hysterectomy, and Lymphadenectomy.

Paul A. Disilvestro
Expertise in
28
conditions
Dr. Paul A. Disilvestro
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Expertise in
28
conditions
Dr. Paul A. Disilvestro
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

Affinity Physicians Llc.

455 Toll Gate Rd, 
Warwick, RI 
 (47.6 mi)
401-737-7010
Languages Spoken:
English
See accepted insurances

Paul Disilvestro is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Warwick, Rhode Island. Dr. Disilvestro is highly rated in 28 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Lymphadenectomy, and Hysterectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Horowitz's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 16 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile